Cargando…

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome

INTRODUCTION: Down syndrome (DS) is associated with an almost universal development of Alzheimer's disease. Individuals with DS are therefore an important population for randomized controlled trials to prevent or delay cognitive decline, though it is essential to understand the time course of e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Startin, Carla M., Hamburg, Sarah, Hithersay, Rosalyn, Al-Janabi, Tamara, Mok, Kin Y., Hardy, John, Strydom, Andre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier, Inc 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374283/ https://www.ncbi.nlm.nih.gov/pubmed/30503169 http://dx.doi.org/10.1016/j.jalz.2018.08.009

Ejemplares similares

The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2016)

Aging related cognitive changes associated with Alzheimer's disease in Down syndrome
por: Firth, Nicholas C., et al.
Publicado: (2018)

Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

The Association between Physical Activity and CAMDEX-DS Changes Prior to the Onset of Alzheimer’s Disease in Down Syndrome
por: Pape, Sarah E., et al.
Publicado: (2021)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
por: Startin, Carla M., et al.
Publicado: (2019)

Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years
por: Hithersay, Rosalyn, et al.
Publicado: (2018)

Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome
por: D’Souza, Hana, et al.
Publicado: (2020)

Health comorbidities and cognitive abilities across the lifespan in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2020)

Developing an Informant Questionnaire for Cognitive Abilities in Down Syndrome: The Cognitive Scale for Down Syndrome (CS-DS)
por: Startin, Carla M., et al.
Publicado: (2016)

The importance of understanding individual differences in Down syndrome
por: Karmiloff-Smith, Annette, et al.
Publicado: (2016)

Comparison of Receptive Verbal Abilities Assessed Using the KBIT-2 and BPVS3 in Adults With Down Syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

The mismatch negativity as an index of cognitive abilities in adults with Down syndrome
por: Saini, Fedal, et al.
Publicado: (2023)

Dynamic Causal Modeling of the Relationship between Cognition and Theta–alpha Oscillations in Adults with Down Syndrome
por: Hamburg, Sarah, et al.
Publicado: (2019)

Comparison of resting-state EEG between adults with Down syndrome and typically developing controls
por: Hamburg, Sarah, et al.
Publicado: (2021)

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
por: Strydom, Andre, et al.
Publicado: (2018)

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2020)

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review
por: Hamburg, Sarah, et al.
Publicado: (2019)

Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer’s disease
por: Nakamura, Akinori, et al.
Publicado: (2018)

Clinically Relevant Changes for Cognitive Outcomes in Preclinical and Prodromal Cognitive Stages: Implications for Clinical Alzheimer Trials
por: Borland, Emma, et al.
Publicado: (2022)

Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models
por: Hom, Christy L., et al.
Publicado: (2021)

MRI-based Alzheimer’s disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer’s disease
por: Liu, Wanting, et al.
Publicado: (2021)

Neuropsychological assessment in preclinical and prodromal Alzheimer disease: a global perspective
por: Watermeyer, Tamlyn, et al.
Publicado: (2019)

The use of hippocampal grading as a biomarker for preclinical and prodromal Alzheimer's disease
por: Morrison, Cassandra, et al.
Publicado: (2023)

Brainstem substructures and cognition in prodromal Alzheimer’s disease
por: Dutt, Shubir, et al.
Publicado: (2021)

Intraindividual variability across cognitive tasks as a potential marker for prodromal Alzheimer’s disease
por: Kälin, Andrea M., et al.
Publicado: (2014)

Cognitive Trajectories in Preclinical and Prodromal Alzheimer’s Disease Related to Amyloid Status and Brain Atrophy: A Bayesian Approach
por: Teipel, Stefan J, et al.
Publicado: (2023)

Sleep and Tau Pathology in Vietnam War Veterans with Preclinical and Prodromal Alzheimer’s Disease
por: Andrews, Murray, et al.
Publicado: (2021)

The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease (TRC-PAD) Project: An Overview
por: Aisen, P.S., et al.
Publicado: (2020)

Structural Connectivity in Down Syndrome and Alzheimer’s Disease
por: Saini, Fedal, et al.
Publicado: (2022)

Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests
por: Benejam, Bessy, et al.
Publicado: (2020)

The effect of diagnostic criteria on outcome measures in preclinical and prodromal Alzheimer's disease: Implications for trial design
por: Bertens, Daniela, et al.
Publicado: (2017)

Time Perception in Prodromal Alzheimer's Dementia and in Prodromal Dementia With Lewy Bodies
por: Pai, Ming-Chyi, et al.
Publicado: (2021)

Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2021)

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain
por: Alić, Ivan, et al.
Publicado: (2020)

Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
por: Meles, Sanne K., et al.
Publicado: (2021)

A cognitive stress test for prodromal Alzheimer's disease: Multiethnic generalizability
por: Curiel Cid, Rosie E., et al.
Publicado: (2019)

Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain
por: Alić, Ivan, et al.
Publicado: (2021)

Blood Biomarkers for Alzheimer’s Disease in Down Syndrome
por: Montoliu-Gaya, Laia, et al.
Publicado: (2021)

Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer’s Disease (TRC-PAD)
por: Walter, S., et al.
Publicado: (2020)

Inflammaging as a prodrome to Alzheimer's disease
por: Giunta, Brian, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ha1cm611t9o8f21vmtsr5istv9